Session Themes Opportunities & Lessons Learned Establishing Precision Medicine Programs in Oncology Session Chair: Fred Ashbury, Viviphi Ltd. A Discussion on Increasing Patient Access To Investigational Drugs Session Chair: Marty Tenenbaum, Cancer Commons How Patients Can Advance Precision Medicine and Why You Should Care Session Chair: Moira Quinn, Charlotte Center City Partners Trends in Comprehensive Study and Biological Sample Management Session Chair: Andrew Brooks, Bioprocessing Solutions Alliance Automating Evidence-based Gene Panel Design Session Chair: Mark Kiel, Genomenon, Inc. Call for Oncologists to Learn About Precision Medicine Session Chair: Vincent Miller, Foundation Medicine Infrastructure and Computational Tools in Support of Research and Genomic Medicine Session Chair: Elaine R. Mardis, Nationwide Children’s Hospital Value-Based Care Models Increase Patient Outcomes and Lower Healthcare Cost Session Chair: Stuart Goldberg, Cota Healthcare Inc. Advancing Precision Medicine in Oncology: The Molecular Pathologist’s Role Session Chair: Chris Cournoyer, N-of-One Accelerating Clinical Trials Using Comprehensive Liquid Biopsy Session Chair: Daniel Simon, Guardant Health Why Subsets are the Practice Session Chair: Scott Zeger, Johns Hopkins Bloomberg School of Public Health Informed Health Decisions Through Creating a Learning Ecosystem Session Chair: Kenneth J. Pienta, Johns Hopkins University ME/CFS: The Mysterious Illness Science Has Yet to Unravel Session Chair: Zaher Nahle, Solve ME/CFS Initiative Delivering Precision Oncology in the Genomics Era Session Chair: Rebecca Brandes, Agilent IT Solutions in Support of Molecular and Genetics Labs Session Chair: Chris Callahan, Sunquest Metabolomics and its Role in Precision Medicine Session Chair: John Ryals, Metabolon Status Quo of Genome Sequencing in Cancer & Beyond Session Chair: Charles M. Perou, GeneCentric Diagnostics An Update on All of Us (PMI) Session Chair: Geoffrey Ginsburg, Duke University School of Medicine Human Genomics is Fueling Drug Discovery Session Chair: Rick Dewey, Regeneron Genetics Center The Value of Data Sharing Session Chair: Kathy Giusti, Multiple Myeloma Research Foundation Reforming Clinical Trials Session Chair: Janet Woodcock, FDA Data Science to Advance Precision Medicine Session Chair: Eric Schadt, Icahn School of Medicine Why Patient Engagement is Important Session Chair: Frank Ingari, CureForward Approaches towards Understanding and Enhancing Human Longevity Session Chair: Brad Perkins, Human Longevity Leaders in Academia and Industry to Foster Biotechnology Session Chair: Ralph Snyderman, Duke University Genomics & Precision Medicine in the “Real World” Session Chair: Jonathan S. Berg, UNC-Chapel Hill Single Cell Genomics: Emerging Applications Session Chair: John Mikszta, BD Technologies New Trends and Emerging Technologies Session Chair: Mark Levin, Third Rock Ventures Reimbursements – The Payor Perspective Session Chair: Lee Newcomer, UnitedHealthcare Novel Approaches to Infectious Disease Diagnosis Session Chair: Christopher W. Woods, Duke University Mobile Health is Changing Healthcare Session Chair: Eric Perakslis, Takeda Liquid Biopsy is Propelling Cancer Diagnostics Research Session Chair: John Beeler, Inivata The Role of the Human Microbiome Session Chair: Lawrence David, Duke University CRISPR – The Genome Engineering Revolution Session Chair: Charles Gersbach, Duke Recent Developments in Cancer Immunology & Immunotherapy Session Chair: Matthias Gromeier, Duke University Medical CenterSee Program Schedule ->
